Health Care & Life Sciences
Articles
Will ACOs really get off the ground?
The hype over accountable care organizations—something every major hospital in Indianapolis is moving to become—is increasingly being laced with skepticism as the economics behind the idea get more scrutiny.
Show-me state stings SynCare
Indianapolis-based SynCare LLC has been touting its growth in Missouri since it entered the market in 2009. But now SynCare’s excursions in the show-me state have turned into a nightmare.
Brokers ‘devastated’ by reform rule
The decision last year by the U.S. Department of Health and Human Services not to exclude health insurance brokers commissions from a provision in the 2010 health reform law has been “devastating to brokers,” broker advocate Janet Trautwein said during an August speech in Fishers, and there are signs that Congress will act to reverse the policy.
Gloomy outlook for medical device makers
The next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.
Roche hopes to prosper from austerity
Executives at Roche Diagnostics expect the wave of austerity measures being taken by western governments—including the United States—to as much as double its sales of fluid- and DNA-based tests in the next three years.
Study spoils common wisdom on health spending
The Thomson Reuters study that showed Anderson as the highest-spending health care market in the nation also concluded that treatment and spending vary widely from one locale to another with no clear reason based on demographics or health outcomes.
FDA deal with drugmakers raises user fees 6 percent
Drugmakers including Eli Lilly an Co. have agreed with regulators on a 6-percent increase in review fees as part of reauthorizing the drug-approval process through fiscal 2017.
Indiana company quits Missouri Medicaid contract
Indianapolis-based SynCare has ended its contract to screen Missouri Medicaid recipients after numerous complaints about its job performance.
Missouri health care advocates decry Indiana contractor
Indianapolis-based SynCare LLC, hired to determine the eligibility of Missouri Medicaid patients for in-home care, has "been a complete disaster from the beginning," statewide health care advocates charge.
Lawyer: Expect more hospital-doc lawsuits
With hospitals having scooped up hundreds of physicians in the past three years—putting nearly all of them under non-compete agreements—there are bound to be legal tussles when some of those physicians decide their new matches aren’t exactly made in heaven.
Savings power of HSAs appears to wane
As consumer-directed health plans become more prevalent, their power to save money for employers is waning, according to the latest survey by Indianapolis-based United Benefit Advisors.
AIT’s Evans gave $48M to start Marian med school
Marian disclosed Evans’ 2010 donation Wednesday as it held a groundbreaking ceremony for its medical and nursing school building, which will be called the Michael A. Evans Center for Health Sciences.
Q&A
Angela Smith, an attorney for hospitals and physicians at Indianapolis-based Hall Render Killian Heath & Lyman P.C., spoke about Medicare’s value-based purchasing program, a federal initiative that will attempt to shift health care payments from the fee-for-service model to one based on health outcomes. On July 1, hospitals began being scored on their performance in 13 categories, including processes, patient outcomes and patient satisfaction surveys. How hospitals score could boost or diminish all their Medicare payments by as much as 1 percent, beginning in October 2012.
Roche Diagnostics to get indirect boon from new test
New drug for metastatic melanoma packaged with genetic test should help Roche sell more of its cobas 4800 laboratory testing systems.
Study: Hospital-doc hookups raising costs
Indianapolis doctor tell researchers that hospitals are paying more than $1 million a year to employ some cardiologists.
Lilly spent $1.9M lobbying feds in first quarter
Eli Lilly and Co. spent $1.9 million lobbying the federal government in the first quarter, focusing on the health care overhaul and overseas pricing reform, among many other issues.
WellPoint spent $1.3M on federal lobbying in 2nd quarter
WellPoint lobbied on issues tied to the overhaul's implementation and regulations for accountable care organizations, which are networks of hospitals, doctors, rehabilitation centers and other providers that coordinate a patient's care.
Arcadia Resources to delist stock amid cash crunch
Arcadia Resources Inc.’s share price dwindled to just 5 cents as of late Tuesday morning, following the company's announcement that it was delisting its stock and had suffered another quarterly loss.
Daniels says smoking ban has chance to pass next year
The governor says he wants to see the percentage of adult Hoosiers who smoke drop to 20 percent by the end of his term. A recent report put the state's smoking rate at a historic low of 21.1 percent.